Mundipharma Korea launches long-acting painkiller patch

Published: 2012-05-17 06:57:00

Updated: 2012-05-17 06:57:00

Mundipharma Korea is launching Norspan (buprenorphine) transdermal patch that combines sustained release active ingredient with better analgesic effects and simplicity in use for helping heal chronic pain.

Norspan is used in the management of moderate to severe pain which is not relieved by su...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK